Member Info for Laura2022

Are allowing buying as we speak?

Interactive Investor - yes

Others?

I posted ONCE !!

Newuncle

Maybe just focus on eleg ??

NU

Yes, ELEG going well

About Iconic Labs

Iconic is a media and technology business focused on the identification, acquisition and growth of technology driven companies in the online media, artificial intelligence, and big data gathering, processing and analysis sectors. 

We work with lean online companies that can scale rapidly, operate internationally with an inexpensive footprint, and provide a broad array of services across various sectors through the effective use of information and video gathering, data mining, just in time processing, and online collaboration technology. 

Icon mgmt are in tech background too

So A.I would make sense

Yes Aklee

And very hard to buy at present

Can't buy

It's 2.14p to 2.35p

Gregory

Yes, IG said same, all brokers will be ready today

Fonzi

Well.done

Have u seen ICON rumours A.I

Accord9ng to telegram group

I've added more

Great article KingHomer

Yes, OSD, would expect a rich news period before June 30th year end

Managed to get a small amount

When other providers allow this could go big like CTAI etc FPP

HL, IG BARC not yet

Interactive Investor- yes

Or premiums

Maybe DrJ was correct about Peel holding strong for rise /other entity

I've filtered 2 people already, including them

Pantheon Resources plc (AIM:PANR, OTCQX: PTHRF) ("Pantheon" or the "Company"), an oil and gas company developing the Kodiak and Ahpun oil fields in close proximity to pipeline and transportation infrastructure on Alaska's North Slope, today announces the completion of Megrez-1 flow testing.

Lower Sagavanirktok 3 Formation Flow Test:

· Two intervals were perforated at 4,830-4,850ft measured depth and 4,930-4,950ft measured depth, and then, after running the completion, lifted to surface with nitrogen.

· The well produced at a rate in excess of 2,000 barrels of liquid per day, with no appreciable quantities of oil or gas recovered.

· The well was shut in during the evening of 20 May 2025 BST and will now be suspended indefinitely pending further evaluation of the results to date.

· The results of the Megrez-1 exploration well has no bearing on the already discovered 1.57 billion barrels of marketable liquids (ANS Crude) and 6.6 Trillion Cubic Feet of natural gas independently certified resources on the Company's Ahpun and Kodiak projects.

Physiomics plc

1,863 followers

18h

In the second part of our series with Weatherden, we explore how Model-Informed Drug Development (MIDD) can help trial sponsors not only meet the FDA’s dose optimisation expectations, but make smarter, data-driven decisions throughout oncology drug development.

Our article dives into how modelling supports dosing decisions – from preclinical stages and planning FIH trials, through to RP2D selection and clinical development strategy - and while this guidance is focused on oncology, the benefits of robust, early modelling go far beyond into other disease areas.

As we highlight in the article, embedding MIDD into your development strategy is not just about regulatory alignment; it's about making smarter, more patient-centred decisions that reduce risk, increase efficiency, and ultimately improve outcomes.

Thanks Ralph

Do you think that DoseMeRx new tech is PYC.tech embedded ?